• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

aTyr Pharma, Inc. - Common Stock (NQ:LIFE)

1.900 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.900
Bid (Size) 1.900 (15)
Ask (Size) 1.950 (20)
Prev. Close 1.900
Today's Range 1.900 - 1.900
52wk Range 1.630 - 2.090
Shares Outstanding 54,291,754
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Millionaire Makers: 7 Stocks You Can Buy for $2 That Can 10X by 2025
June 05, 2024
These 10X penny stocks have the potential to mint millionaires with enough capital but buy wisely as the risk is real. 
Via InvestorPlace
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
June 03, 2024
Ticker symbol change to take effect on Wednesday, June 5, 2024 
From aTyr Pharma, Inc.
Via GlobeNewswire

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+12.4%
+12.4%

More News

Read More
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 24, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Recap: aTyr Pharma Q4 Earnings
March 14, 2024
Via Benzinga
aTyr Pharma's Earnings Outlook
March 13, 2024
Via Benzinga
Analyst Expectations for aTyr Pharma's Future
September 21, 2023
Via Benzinga
aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
May 15, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
May 14, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma to Present at Upcoming Investor Conferences
May 06, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
LIFE Stock Earnings: aTyr Pharma Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
Via InvestorPlace
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
May 02, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via Benzinga
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Via InvestorPlace
LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023
March 14, 2024
Via InvestorPlace
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
March 14, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
February 28, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Earnings Scheduled For March 14, 2024
March 14, 2024
Via Benzinga
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
February 21, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
The 3 Best Penny Stocks to Buy in February 2024
February 15, 2024
Via InvestorPlace
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
January 18, 2024
From aTyr Pharma, Inc.
Via GlobeNewswire
Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!
November 13, 2023
Via IssueWire
Topics Religion
Exposures Religion
aTyr Pharma to Present at November Investor Conferences
November 01, 2023
From aTyr Pharma, Inc.
Via GlobeNewswire
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
October 31, 2023
From aTyr Pharma, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is aTyr Pharma, Inc. - Common Stock publicly traded?
Yes, aTyr Pharma, Inc. - Common Stock is publicly traded.
What exchange does aTyr Pharma, Inc. - Common Stock trade on?
aTyr Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for aTyr Pharma, Inc. - Common Stock?
The ticker symbol for aTyr Pharma, Inc. - Common Stock is LIFE on the Nasdaq Stock Market
What is the current price of aTyr Pharma, Inc. - Common Stock?
The current price of aTyr Pharma, Inc. - Common Stock is 1.900
When was aTyr Pharma, Inc. - Common Stock last traded?
The last trade of aTyr Pharma, Inc. - Common Stock was at 06/04/24 04:00 PM ET
What is the market capitalization of aTyr Pharma, Inc. - Common Stock?
The market capitalization of aTyr Pharma, Inc. - Common Stock is 103.15M
How many shares of aTyr Pharma, Inc. - Common Stock are outstanding?
aTyr Pharma, Inc. - Common Stock has 103M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap